BioMarin Pharmaceutical Inc. · 22 hours ago
Intern, Quality Assurance, Global Quality Management System
BioMarin Pharmaceutical Inc. is a global biotechnology company focused on translating genetic discoveries into new medicines. The Global QMS Transformation Intern will support initiatives aimed at enhancing user experience and driving continuous improvement in Quality Risk Management processes within the pharmaceutical product lifecycle.
BiotechnologyDeveloper PlatformPharmaceutical
Responsibilities
The Global QMS Transformation Intern will support initiatives to enhance the user experience and drive continuous improvement during a Quality Risk Management process transformation
This role involves creating practical tools and resources that make QRM concepts accessible and actionable across the pharmaceutical product lifecycle
Initiatives may include, but are not limited to: Developing a visual map illustrating where risk management is applied and how QRM principles integrate across development, manufacturing, and post-market stages
Creating a clear, user-friendly glossary of QRM terms and a communication toolkit to improve cross-functional understanding and application
Designing a beginner-friendly QRM guide and apply it to a small-scale pilot risk assessment for a real or hypothetical process
Qualification
Required
Clear written and visual communication: ability to simplify complex ideas for diverse audiences
Proficiency with presentation/diagramming tools (e.g., PowerPoint, Visio, or equivalent)
Organization and follow‑through: planning work, meeting deadlines, and iterating with feedback
Curiosity about pharmaceutical quality systems and risk management; willingness to learn QRM processes across the lifecycle (development → post‑market)
Student in their 3rd or 4th year of Undergrad or Master's Candidates in one of the following fields (or closely related disciplines): Pharmaceutical Sciences, Chemistry / Biochemistry, Chemical Engineering / Biomedical Engineering, Quality Assurance / Regulatory Affairs, Life Sciences (Biology, Microbiology)
Must be available to work full time, 40 hours a week
Must be currently enrolled as a full-time student at an accredited U.S. based university or college and enrolled in the fall term after the completion of the internship OR have graduated within 1 year of the start of the program
Must be able to relocate if necessary and work at the designated site for the duration of the internship for on-site, hybrid roles. Some positions will be open to remote interns, but employee must be within United States borders
Preferred
Basic familiarity with ICH Q9(R1) and QRM tools (FMEA, risk matrices, PHA); comfort mapping processes and controls
Experience building glossaries, playbooks, or training decks for cross‑functional teams
Exposure to SharePoint/Viva, document control, or QMS platforms (e.g., Veeva Quality)
Interest in human‑centered design or UX methods applied to process understanding
Data visualization skills (turning risk concepts into intuitive diagrams/flows)
Benefits
Paid hourly wage, paid company holidays, and sick time
Apply skills and knowledge learned in the classroom to on-the-job experiences
Comprehensive, value-added project(s)
Develop skills specific to your major.
Opportunities for professional development by building relationships and learning about other parts of the business.
Participate in company all hands meetings, monthly community lunches
Corporate office amenities such as: 24/7 on-site gym, coffee truck, snacks
Access to Employee Resource Groups
Company
BioMarin Pharmaceutical Inc.
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery.
H1B Sponsorship
BioMarin Pharmaceutical Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (34)
2024 (23)
2023 (24)
2022 (26)
2021 (24)
2020 (19)
Funding
Current Stage
Public CompanyTotal Funding
$585.8M2020-05-11Post Ipo Debt· $585.8M
1999-07-26IPO
Recent News
2026-01-08
Morningstar.com
2026-01-07
Company data provided by crunchbase